Trial NCT04650204

View at ClinicalTrials.gov 
Org. Study IDs: 19-006286
Secondary IDs: MC2072 NCI-2020-01290

Last trial update was posted on 2023-06-22

MeSH Interventions

Anticonvulsants

MeSH Conditions

Drug Resistant Epilepsy Epilepsies, Partial Epilepsy Glioma Seizures

Other Conditions

Intractable Epilepsy Malignant Glioma Seizure Disorder WHO Grade 2 Glioma WHO Grade 3 Glioma

Stopping Reasons

The funding sponsor, EISAI, sold the US rights to the medication and can no longer provide it to patients for the study.

Limitations And Caveats

Study was terminated due to the funding sponsor(EISAI) sold the US rights to the medication and can no longer provide it to patients for the study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID